A compound of the formula (I), (II), (III) or (IV): wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof useful as a vascular adhesion protein-1 (VAP-1) inhibitor, a pharmaceutical composition, a method for preventing or treating a VAP-1 associated disease, especially macular edema, which method includes administering an effective amount of the compound or a pharmaceutically acceptable salt thereof to a subject, and the like.
公式(I),(II),(III)或(IV)的化合物:其中每个符号如规范中所定义,或其药学上可接受的盐,可用作血管黏附蛋白-1(VA
P-1)
抑制剂,制药组合物,预防或治疗VA
P-1相关疾病,特别是黄斑
水肿的方法,该方法包括向受试者投予化合物或其药学上可接受的盐的有效量等。